| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |